Condition
Diseases of Mitral Valve
Total Trials
5
Recruiting
0
Active
0
Completed
1
Success Rate
33.3%-53% vs avg
Key Insights
Highlights
Success Rate
33% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 90/100
Termination Rate
40.0%
2 terminated out of 5 trials
Success Rate
33.3%
-53.2% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
33% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (1)
P 4 (1)
Trial Status
Terminated2
Completed1
Suspended1
Unknown1
Trial Success Rate
33.3%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT02505074UnknownPrimary
Natural History of Melody Valve in the Mitral and Tricuspid Position
NCT02435303Phase 2Terminated
Effect of Sildenafil for Sustained PAH After MV Surgery (SUPERIOR Trial)
NCT01536717Phase 4SuspendedPrimary
Comparison of the Local Anaesthetics Articaine and Bupivacaine in Treatment of Acute Sternum Pain After Heart Surgery
NCT01708265Not ApplicableTerminated
The Dutch Asymptomatic Mitral Regurgitation Trial
NCT02371863Completed
Normal Values in Stress Echocardiographic Parameters in Patients After Successful Mitral Valve Repair for Organic MR
Showing all 5 trials